Off-label testosterone therapy in men with diabetes is associated with higher long-term cardiovascular and mortality risk than therapy in confirmed hypogonadism
28 August 2026 (09:15 - 09:40)
Organised by: 
About the speaker
University Heart Center Freiburg, Freiburg (Germany)
2 More presentations in this session
Doctor Y. Liu (Taipei, TW)
Doctor Y. Salama (Tangier, MA)
Access the full session
The Event
ESC Congress 2026
28 August 2026
09:15 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
